IL18 is a potent adjuvant for Newcastle disease and infectious bursal disease vaccine, indicating that the carvacrol-induced upregulation of IL-18R may have the potential to improve in ovo vaccination for Marek’s disease [44, 45]. Here, IL18 is linked to Newcastle disease.